Vanderbilt University Medical Center: Nashville Biosciences And Illumina Announce Sequencing Agreement With Amgen
January 10, 2023
January 10, 2023
NASHVILLE, Tennessee, Jan. 10 (TNSpar) -- Vanderbilt University Medical Center issued the following news on Jan. 9, 2023:
Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.
The sample cohort is primarily made up . . .
Nashville Biosciences LLC, a wholly owned subsidiary of Vanderbilt University Medical Center, and Illumina Inc., a global leader in DNA sequencing and array-based technologies, today announced an agreement with Amgen, a global biopharmaceutical company, to whole-genome sequence approximately 35,000 DNA samples.
The sample cohort is primarily made up . . .